Difficulty: Medium
Average Score: 79%
Practice
A 53-year-old woman with long-standing hypertension has already been treated with a ß-blocker and a calcium channel blocker, which have failed to control her blood pressure. She is now treated with losartan. Which of the following statements is correct regarding its pharmacokinetics?
Correct answer
C
Rationale
Rationale:
The correct answer is C) Extensive first-pass metabolism.
Explanation:
1. **Why C is correct**: Losartan undergoes extensive first-pass metabolism in the liver by the enzyme CYP3A4 to its active metabolite, E-3174. This metabolite is responsible for most of the drug's effects on blood pressure regulation.
2. **Why others are wrong**:
- A) Losartan is not converted to an inactive metabolite. Instead, it is converted to an active metabolite.
- B) Losartan is primarily eliminated in the urine and feces, not via skin loss.
- D) Losartan has a high binding affinity to plasma proteins, specifically albumin, which limits its distribution into tissues.
Educational context:
Understanding the pharmacokinetics of drugs used in cardiovascular diseases is crucial for healthcare providers to optimize treatment and manage potential drug interactions and adverse effects. Losartan's metabolism pathway highlights the importance of liver function in drug processing and the impact on therapeutic outcomes. This knowledge helps in making informed decisions for patient care and medication management.
The correct answer is C) Extensive first-pass metabolism.
Explanation:
1. **Why C is correct**: Losartan undergoes extensive first-pass metabolism in the liver by the enzyme CYP3A4 to its active metabolite, E-3174. This metabolite is responsible for most of the drug's effects on blood pressure regulation.
2. **Why others are wrong**:
- A) Losartan is not converted to an inactive metabolite. Instead, it is converted to an active metabolite.
- B) Losartan is primarily eliminated in the urine and feces, not via skin loss.
- D) Losartan has a high binding affinity to plasma proteins, specifically albumin, which limits its distribution into tissues.
Educational context:
Understanding the pharmacokinetics of drugs used in cardiovascular diseases is crucial for healthcare providers to optimize treatment and manage potential drug interactions and adverse effects. Losartan's metabolism pathway highlights the importance of liver function in drug processing and the impact on therapeutic outcomes. This knowledge helps in making informed decisions for patient care and medication management.